| TX | HB638 | Intro
Sine Die | Relating to access to certain investigational drugs, biological products, and devices used in clinical trials by patients with severe chronic diseases.
[Detail][Text][Discuss] | 2023-05-11
Laid on the table subject to call |
| TX | HB2180 | Intro
Sine Die | Relating to the application of prescription drug price rebates to reduce health benefit plan enrollee cost sharing.
[Detail][Text][Discuss] | 2023-05-10
Placed on General State Calendar |
| TX | HB1754 | Intro
Sine Die | Relating to the disclosure of certain prescription drug information by a health benefit plan.
[Detail][Text][Discuss] | 2023-05-09
Laid on the table subject to call |
| TX | HB1240 | Intro
Sine Die | Relating to the authority of a physician to provide and dispense and to delegate authority to provide and dispense certain drugs.
[Detail][Text][Discuss] | 2023-05-06
Committee report sent to Calendars |
| TX | HB920 | Intro
Sine Die | Relating to the use of medication designated for treatment of respiratory distress on public and private school campuses.
[Detail][Text][Discuss] | 2023-05-05
Laid on the table subject to call |
| TX | HB2529 | Intro
Sine Die | Relating to written notification provided by drug manufacturers regarding the cause of generic insulin prescription drug unavailability.
[Detail][Text][Discuss] | 2023-05-01
To House Public Health Committee |
| TX | SB1113 | Intro
Sine Die | Relating to prescription drug formularies applicable to the Medicaid managed care program.
[Detail][Text][Discuss] | 2023-04-26
To Senate Health & Human Services Committee |
| TX | SB1150 | Intro
Sine Die | Relating to prior authorization for prescription drug benefits related to the treatment of chronic and autoimmune diseases.
[Detail][Text][Discuss] | 2023-04-26
To Senate Health & Human Services Committee |
| TX | SB1619 | Intro
Sine Die | Relating to the determination of prescription drug reimbursement amounts under the Medicaid vendor drug program.
[Detail][Text][Discuss] | 2023-04-26
To Senate Health & Human Services Committee |
| TX | HB826 | Intro
Sine Die | Relating to modification of certain prescription drug benefits and coverage offered by certain health benefit plans.
[Detail][Text][Discuss] | 2023-04-25
To House Insurance Committee |
| TX | HB1293 | Intro
Sine Die | Relating to the reimbursement of prescription drugs under Medicaid and the child health plan program.
[Detail][Text][Discuss] | 2023-04-25
To House Human Services Committee |
| TX | HB3715 | Intro
Sine Die | Relating to access to all prescribed medications by residents in certain long-term care facilities.
[Detail][Text][Discuss] | 2023-04-25
To House Human Services Committee |
| TX | HB2743 | Intro
Sine Die | Relating to procedures regarding the court-ordered administration of psychoactive medication for criminal defendants who are found incompetent to stand trial.
[Detail][Text][Discuss] | 2023-04-24
To House Corrections Committee |
| TX | HB4886 | Intro
Sine Die | Relating to sexually violent predators and the prosecution of certain offenses involving prohibited items at correctional or civil commitment facilities; creating a criminal offense.
[Detail][Text][Discuss] | 2023-04-24
To House Corrections Committee |
| TX | SB1138 | Intro
Sine Die | Relating to health benefit plan coverage of clinician-administered drugs.
[Detail][Text][Discuss] | 2023-04-19
To Senate Health & Human Services Committee |
| TX | SB2402 | Intro
Sine Die | Relating to the creation, management, and administration of the Texas Pharmaceutical Initiative.
[Detail][Text][Discuss] | 2023-04-19
To Senate Health & Human Services Committee |
| TX | HB2985 | Intro
Sine Die | Relating to prior authorization for prescription drug benefits related to the prevention of human immunodeficiency virus infections.
[Detail][Text][Discuss] | 2023-04-18
To House Insurance Committee |
| TX | HB5230 | Intro
Sine Die | Relating to health benefit plan coverage of prescription drugs for serious mental illnesses and opioid and substance use disorders.
[Detail][Text][Discuss] | 2023-04-18
To House Insurance Committee |
| TX | HB1373 | Intro
Sine Die | Relating to a pilot program for the safe disposal of controlled substance prescription drugs.
[Detail][Text][Discuss] | 2023-04-17
To House Public Health Committee |
| TX | HB2079 | Intro
Sine Die | Relating to the authority of pharmacists to order and furnish certain prescription drugs.
[Detail][Text][Discuss] | 2023-04-17
To House Public Health Committee |
| TX | HB3285 | Intro
Sine Die | Relating to Medicaid coverage and reimbursement for the provision of certain digital therapeutics.
[Detail][Text][Discuss] | 2023-04-04
To House Human Services Committee |
| TX | HB1543 | Intro
Sine Die | Relating to a statewide standing order prescribing opioid antagonists.
[Detail][Text][Discuss] | 2023-04-03
To House Public Health Committee |
| TX | HB5298 | Intro
Sine Die | Relating to a pilot program under which lockable, tamper-evident containers are used by participating pharmacies when dispensing schedule II controlled substances.
[Detail][Text][Discuss] | 2023-03-24
To House Public Health Committee |
| TX | HB4801 | Intro
Sine Die | Relating to the use of the money in the Opioid Abatement Account.
[Detail][Text][Discuss] | 2023-03-23
To House Public Health Committee |
| TX | SB2436 | Intro
Sine Die | Relating to covered benefits under the child health plan.
[Detail][Text][Discuss] | 2023-03-23
To Senate Health & Human Services Committee |
| TX | SB2455 | Intro
Sine Die | Relating to the medical use of low-THC cannabis by patients with certain medical conditions.
[Detail][Text][Discuss] | 2023-03-23
To Senate Health & Human Services Committee |
| TX | SB2448 | Intro
Sine Die | Relating to the use of funds appropriated by the Department of State Health Services to deliver low-dose, at-home racemic ketamine via telehealth to improve healthcare access and mental health outcomes across rural and high-risk populations.
[Detail][Text][Discuss] | 2023-03-23
To Senate Health & Human Services Committee |
| TX | HB4876 | Intro
Sine Die | Imposing liability on those who perform or assist unlawful abortions.
[Detail][Text][Discuss] | 2023-03-23
To House Judiciary & Civil Jurisprudence Committee |
| TX | SB2535 | Intro
Sine Die | Relating to the use of prescription glucagon medication on public and private school campuses.
[Detail][Text][Discuss] | 2023-03-23
To Senate Education Committee |
| TX | HB5087 | Intro
Sine Die | Relating to the regulation of abortion, including abortion complication reporting and the repeal of certain laws prohibiting abortion.
[Detail][Text][Discuss] | 2023-03-23
To House State Affairs Committee |
| TX | HB4583 | Intro
Sine Die | Relating to the prescribing of opioids for acute pain.
[Detail][Text][Discuss] | 2023-03-22
To House Public Health Committee |
| TX | HB4561 | Intro
Sine Die | Relating to the establishment of the Alternative Mental Health Therapy Research Consortium and to certain plans, programs, and studies related to the provision of those alternative mental health therapies.
[Detail][Text][Discuss] | 2023-03-22
To House Public Health Committee |
| TX | SB2201 | Intro
Sine Die | Relating to certain prescription drug benefits under the Medicaid managed care program.
[Detail][Text][Discuss] | 2023-03-22
To Senate Health & Human Services Committee |
| TX | HB4799 | Intro
Sine Die | Relating to the provision of opioid antagonists to clients on discharge from a chemical dependency treatment facility.
[Detail][Text][Discuss] | 2023-03-22
To House Public Health Committee |
| TX | HB4693 | Intro
Sine Die | Relating to entities that provide services to rural Texans and in rural counties.
[Detail][Text][Discuss] | 2023-03-22
To House Health Care Reform, Select Committee |
| TX | HB4800 | Intro
Sine Die | Relating to prohibited discriminatory practices by pharmaceutical drug manufacturers against patient assistance program applicants.
[Detail][Text][Discuss] | 2023-03-22
To House Health Care Reform, Select Committee |
| TX | HB4798 | Intro
Sine Die | Relating to governmental health benefit plan coverage for opioid antagonists and associated devices.
[Detail][Text][Discuss] | 2023-03-22
To House Insurance Committee |
| TX | SB1700 | Intro
Sine Die | Relating to the licensing and authority of advanced practice registered nurses.
[Detail][Text][Discuss] | 2023-03-21
To Senate Health & Human Services Committee |
| TX | SB1959 | Intro
Sine Die | Relating to the authority of a physician to supervise or delegate the prescribing or ordering of a drug or device to a physician assistant or advanced practice registered nurse.
[Detail][Text][Discuss] | 2023-03-21
To Senate Health & Human Services Committee |
| TX | HB4347 | Intro
Sine Die | Relating to the application of prescription drug price reductions; imposing a civil penalty.
[Detail][Text][Discuss] | 2023-03-21
To House Health Care Reform, Select Committee |
| TX | HB4348 | Intro
Sine Die | Relating to the right to try cutting-edge treatments for patients with life-threatening or severely debilitating illnesses.
[Detail][Text][Discuss] | 2023-03-21
To House Public Health Committee |
| TX | HB4423 | Intro
Sine Die | Relating to the establishment of the Psilocybin Research Advisory Council.
[Detail][Text][Discuss] | 2023-03-21
To House Public Health Committee |
| TX | HB4341 | Intro
Sine Die | Relating to promoting, prescribing, administering, or dispensing prescription drugs for off-label use.
[Detail][Text][Discuss] | 2023-03-21
To House Public Health Committee |
| TX | HB4371 | Intro
Sine Die | Relating to an exemption from sales and use taxes for certain items used by or for certain life sciences campuses.
[Detail][Text][Discuss] | 2023-03-21
To House Ways & Means Committee |
| TX | HB4289 | Intro
Sine Die | Relating to the establishment of a ketamine treatment grant program for veterans, active-duty military, and first responders.
[Detail][Text][Discuss] | 2023-03-21
To House Public Health Committee |
| TX | HB4369 | Intro
Sine Die | Relating to continuing education requirements for dentists regarding pain management with certain prescription medications.
[Detail][Text][Discuss] | 2023-03-21
To House Public Health Committee |
| TX | HB3734 | Intro
Sine Die | Relating to an opioid-related drug overdose response protocol and training on the administration of an opioid antagonist for public school personnel.
[Detail][Text][Discuss] | 2023-03-20
To House Public Education Committee |
| TX | HB3735 | Intro
Sine Die | Relating to the administration of opioid antagonists by a school nurse at public school campuses.
[Detail][Text][Discuss] | 2023-03-20
To House Public Education Committee |
| TX | HB3774 | Intro
Sine Die | Relating to civil and criminal liability for pharmacists and pharmacies that dispense misoprostol.
[Detail][Text][Discuss] | 2023-03-20
To House Public Health Committee |
| TX | HB3912 | Intro
Sine Die | Relating to the applicability of health benefit plan cost-sharing requirements for prescription insulin.
[Detail][Text][Discuss] | 2023-03-20
To House Health Care Reform, Select Committee |
